Colleen Moretti

May 05, 2022

The FDA’s approval of Enhertu in this setting, according to an expert, marks an important milestone and will allow patients with unresectable or metastatic HER2-positive breast cancer to be treated in an earlier line, with the possibility of delaying disease progression.

May 04, 2022

Unrelieved stress may play a part in causing cancer-related cognitive impairment and anxiety, though more research is needed.

May 03, 2022

While a higher risk of heart issues was found in older men years after androgen-deprivation therapy, it is unknown if the risk comes from the treatment or other age-related comorbidities.

May 02, 2022

Cognitive behavioral therapy has been proven to improve insomnia in cancer survivors, but research is lacking in patients who are currently undergoing treatment or who have advanced disease.

April 27, 2022

Imfinzi alone is the standard of care in this patient population, however two combinations may have better outcomes.

April 26, 2022

Alex Mallonee has found it inspiring to depict his mother’s journey with breast cancer through art, and hopes others affected by cancer will feel the same.

April 25, 2022

Treatment with a combination of Ofev and chemotherapy was shown to have a survival benefit in a group of patients with bladder cancer.

April 22, 2022

Watch Dr. Jose Karam, from The University of Texas MD Anderson Cancer Center, discuss surgical options, during the CURE Educated Patient Kidney Cancer Summit.

April 20, 2022

An expert noted that despite the results, all patients with cancer should be aware of their increased risk for developing blood clots.

April 19, 2022

Patients with early-stage breast cancer are advised to ask their provider what the least invasive treatment option is available to them that gives them both a great cure rate and a much better quality of life.

April 19, 2022

Watch Dr. Vitaly Margulis, from UT Southwestern Medical Center, discuss staging, during the CURE Educated Patient Kidney Cancer Summit.

April 18, 2022

Patients with myeloproliferative neoplasms, a group of blood cancers, who plan to conceive should talk with their doctor about their obstetric and medical history and risk of complications, according to an expert.

April 14, 2022

Patients who are part of an advocacy group may be better equipped to understand biomarker testing during a lung cancer diagnosis and feel more empowered.

April 13, 2022

The FDA’s recent approval of Opdivo plus chemotherapy may be beneficial for some patients with non-small cell lung cancer, further highlighting the need for multidisciplinary care.

April 11, 2022

“It’s important for patients to be educated on (next-generation sequencing), because the more we know about a patient’s cancer, the better we can design a personalized treatment plan,” says an expert.

April 05, 2022

Monumental treatment advancements over the past two decades have given patients with thyroid cancer the ability to live longer and better lives, according to an expert from Cleveland Clinic’s Taussig Cancer Institute. However, more work is needed to find curative treatments.

March 31, 2022

Watch Dr. Carlyn Rose Tan, an assistant attending in myeloma service at Memorial Sloan Kettering Cancer Center, present on risk stratification for newly diagnosed patients.

March 30, 2022

Watch Dr. Neha S. Korde, an assistant professor in multiple myeloma service in the Division of Hematology at Memorial Sloan Kettering Cancer Center, present on MGUS/smoldering myeloma.

March 29, 2022

Keytruda was well tolerated and demonstrated practice-changing responses with potential for a curative approach in a group of patients with advanced endometrial cancer, according to an expert.

March 24, 2022

To address symptoms from myeloma that is resistant to treatment, education and communication with care teams are key.

March 23, 2022

Patients with stage 3 melanoma, a type of skin cancer, that has metastasized to the lymph nodes may benefit from skipping lymph node removal surgery and receiving treatment with adjuvant therapy, although more research is needed in this area.

March 21, 2022

One of the hurdles, according to the study’s lead author, is that many patients with cancer are worried about receiving a placebo in a clinical trial.

March 21, 2022

In honor of CURE®’s 20th anniversary, we spoke with experts on how the past 20 years have revolutionized multiple myeloma treatment.

March 18, 2022

Donna McNutt uses her love of fashion to find confidence and motivation — and shares it with others — after a myeloma diagnosis.

March 17, 2022

Durable and deep responses occurred in patients with multiple myeloma after use of a particular CAR-T cell therapy

March 10, 2022

Recently approved, by the Food and Drug Administration, Besremi has demonstrated to be effective and safe for patients with polycythemia vera — adding hope to their treatment regimen.

March 08, 2022

Sara Montiel shares her experience and how time helped her find the confidence she needed for herself and her young daughter

March 07, 2022

Increased resources and technological advances have allowed cancer survivors experiencing psychological side effects to seek help that might not have been available to them 20 years ago.

March 04, 2022

During his college years, Matt Froestad received the diagnosis not once but twice following self-exams.

February 15, 2022

Prehab and rehab may help patients with cancer who are receiving CAR-T cell therapy return to health or even better, but there are still challenges.